Influenza A Virus, H7N9 Subtype
4 clinical trials · Condition
◉ Watch Influenza A Virus, H7N9 Subtype
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant (NCT02957656) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-01 |
| Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old (NCT02274545) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-01 |
| Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals (NCT02151344) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-01 |
| Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults (NCT01995695) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-01 |
Track Influenza A Virus, H7N9 Subtype automatically
Every clearance here is in the API, with alerts when new ones post.